Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
40.3M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
18M
-
Shares change
-
-1.73M
-
Total reported value, excl. options
-
$45.6M
-
Value change
-
-$11M
-
Put/Call ratio
-
0
-
Number of buys
-
18
-
Number of sells
-
-47
-
Price
-
$2.53
Significant Holders of TELA Bio, Inc. - Common Stock (TELA) as of Q3 2024
77 filings reported holding TELA - TELA Bio, Inc. - Common Stock as of Q3 2024.
TELA Bio, Inc. - Common Stock (TELA) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18M shares
of 40.3M outstanding shares and own 44.71% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4.11M shares), AIGH Capital Management LLC (2.47M shares), ORBIMED ADVISORS LLC (2.16M shares), Nantahala Capital Management, LLC (1.92M shares), SILVERARC CAPITAL MANAGEMENT, LLC (1.12M shares), Stonepine Capital Management, LLC (1.11M shares), VANGUARD GROUP INC (904K shares), CITIGROUP INC (750K shares), Velan Capital Investment Management LP (747K shares), and Pentwater Capital Management LP (500K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.